CardiaTec Bio
- Biotech or pharma, therapeutic R&D
CardiaTec is decoding the biology behind cardiovascular disease. The company leverages human multiomics data to better navigate complex disease biology to identify novel and differentiated therapeutics.
CardiaTec is building the first and largest proprietary human heart tissue multiomics dataset. The company has a large and growing network of over 65 hospitals across the US and the UK, screening patients on a 24/7 basis to support the bespoke collection of human cardiac tissues.
The company spun out of the Han Lab at the University of Cambridge and has brought together industry experts from leading organisations including Bristol Myers Squibb, Cleveland Clinic and Recursion Pharmaceuticals.
)
)
)
)
){kind=logo}
){kind=logo}
)
){kind=logo}
)
){kind=logo}
){kind=logo}